Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2011 May 12;23(1):38–45. doi: 10.1016/j.numecd.2011.02.004

Table 1.

Definition of metabolic syndrome according NCEP-ATPIII (7), by direct assessment of abnormality or ongoing therapy.

Factor ATPIII components in DD ATPIII components in HD
Abdominal obesity >102/88 cm waist (M/W) >102/88 cm waist (M/W)
Triglycerides ≥150 mg/dL ≥150 mg/dL or lipid lowering therapy
HDL-cholesterol <40/50 mg/dL (M/W) <40/50 mg/dL (M/W) or lipid lowering therapy
Blood pressure ≥130/≥85 mmHg ≥130/>85 mmHg or antihypertensive therapy
Fasting glucose ≥110 mg/dL ≥110 mg/dL

DD=diagnosis of MetS based on direct measurements of the components.

HD=diagnosis of MetS based on historical exposition, with one or more treated components of the MetS normal at the time of survey.